Sonographic appearance of the uterine cavity following administration of mifepristone and misoprostol for termination of pregnancy

Journal of Clinical Ultrasound

Volumn 34, Issue 6, 2006, Pages 278-282

  Markovitch, Ofer ^a   Tepper, Ron ^a   Klein, Zvi ^a   Fishman, Ami ^a   Aviram, Rami ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

Abortion; Mifepristone; Ultrasonography; Uterine cavity

Indexed keywords

MIFEPRISTONE; MISOPROSTOL;

ADOLESCENT; ADULT; ARTICLE; CALCULATION; CLINICAL ARTICLE; CROWN RUMP LENGTH; CURETTAGE; DOPPLER FLOWMETER; ECHOGRAPHY; EMBRYO DEVELOPMENT; ENDOMETRIUM CELL; FEMALE; GESTATIONAL AGE; HUMAN; MENSTRUAL CYCLE; PREGNANCY TERMINATION; TREATMENT FAILURE; UTERUS CAVITY;

ABORTIFACIENT AGENTS, NONSTEROIDAL; ABORTIFACIENT AGENTS, STEROIDAL; ABORTION, INDUCED; ADOLESCENT; ADULT; FEMALE; HUMANS; MIFEPRISTONE; MISOPROSTOL; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PROSPECTIVE STUDIES; UTERUS;

EID: 33745758088     PISSN: 00912751     EISSN: 10970096     Source Type: Journal    
DOI: 10.1002/jcu.20232     Document Type: Article

References (27)

1. Kahn JG, Becker BJ, MacIsaac L, et al. The efficacy of medical abortion: a meta-analysis. Contraception 2000;61:29.
2. Kruse B, Poppema S, Creinin MD, et al. Management of side effects and complications in medical abortion. Am J Obstet Gynecol 2000;183:865.
3. Heikinheimo O. Clinical pharmacokinetics of mifepristone. Clin Pharmacokinet 1997;33:7.
4. Ulmann A, Silvestre L, Chemama L, et al. Medical termination of early pregnancy with mifepristone (RU 486) followed by a prostaglandin analogue. Study in 16,369 women. Acta Obstet Gynecol Scand 1992;71:278.
5. Christin-Maitre S, Bouchard P, Spitz IM. Medical termination of pregnancy. N Engl J Med 2000;342:946.
6. Thong KJ, Baird DT. Induction of abortion with mifepristone and misoprostol in early pregnancy. Br J Obstet Gynaecol 1992;99:1004.
7. Ulmann A, Silvestre L. RU486: the French experience. Hum Reprod 1994;9:126.
8. Spitz IM, Bardin CW, Benton L, et al. Early pregnancy termination with mifepristone and misoprostol in the United States. N Engl J Med 1998; 338:1241.
9. Rodger MW, Logan AF, Baird DT. Induction of early abortion with mifepristone (RU486) and two different doses of prostaglandin pessary (gemeprost). Contraception 1989;39:497.
10. Aubeny E, Peyron R, Turpin CL, et al. Termination of early pregnancy (up to 63 days of amenorrhea) with mifepristone and increasing doses of misoprostol [corrected]. Int J Fertil Menopausal Stud 1995;40(Suppl 2):85.
11. Creinin MD, Spitz IM. Use of various ultrasonographic criteria to evaluate the efficacy of mifepristone and misoprostol for medical abortion. Am J Obstet Gynecol 1999;181:1419.
12. Peyron R, Aubeny E, Targosz V, et al. Early termination of pregnancy with mifepristone (RU 486) and the orally active prostaglandin misoprostol. N Engl J Med 1993;328:1509.
13. Creinin MD, Schwartz JL, Pymar HC, et al. Efficacy of mifepristone followed on the same day by misoprostol for early termination of pregnancy: report of a randomised trial. BJOG 2001;108:469.
14. Harwood B, Meckstroth KR, Mishell DR, et al. Serum beta-human chorionic gonadotropin levels and endometrial thickness after medical abortion. Contraception 2001;63:255.
15. Aubeny E, Chatellier G. A randomized comparison of mifepristone and self- administered oral or vaginal misoprostol for early abortion. Eur J Contracept Reprod Health Care 2000;5:171.
16. Ashok PW, Flett GM, Templeton A. Mifepristone versus vaginally administered misoprostol for cervical priming before first-trimester termination of pregnancy: a randomized, controlled study. Am J Obstet Gynecol 2000;183:998.
17. El-Refaey H, Nooh R, O'Brien P, et al. The misoprostol third stage of labour study: a randomised controlled comparison between orally administered misoprostol and standard management. BJOG 2000;107:1104.
18. Bartley J, Tong S, Everington D, et al. Parity is a major determinant of success rate in medical abortion: a retrospective analysis of 3161 consecutive cases of early medical abortion treated with reduced doses of mifepristone and vaginal gemeprost. Contraception 2000;62:297.
19. El-Refaey H, Rajasekar D, Abdalla M, et al. Induction of abortion with mifepristone (RU 486) and oral or vaginal misoprostol. N Engl J Med 1995;332:983.
20. Fiala C, Safar P, Bygdeman M, et al. Verifying the effectiveness of medical abortion; ultrasound versus hCG testing. Eur J Obstet Gynecol Reprod Biol 2003;109:190.
21. Cowett AA, Cohen LS, Lichtenberg ES, et al. Ultrasound evaluation of the endometrium after medical termination of pregnancy. Obstet Gynecol 2004;103: 871.
22. Acharya G, Haugen M, Brathen A, et al. Role of routine ultrasonography in monitoring the outcome of medical abortion in a clinical setting. Acta Obstet Gynecol Scand 2004;83:390.
23. Bar-Hava I, Aschkenazi S, Orvieto R, et al. Spectrum of normal intrauterine cavity sonographic findings after first-trimester abortion. J Ultrasound Med 2001;20:1277.
24. Dillon EH, Case CQ, Ramos IM, et al. Endovaginal US and Doppler findings after first-trimester abortion. Radiology 1993;186:87.
25. Chung TK, Cheung LP, Sahota DS, et al. Evaluation of the accuracy of transvaginal sonography for the assessment of retained products of conception after spontaneous abortion. Gynecol Obstet Invest 1998;45:190.
26. Kurtz AB, Shlansky-Goldberg RD, Choi HY, et al. Detection of retained products of conception following spontaneous abortion in the first trimester. J Ultrasound Med 1991;10:387.
27. Wong SF, Lam MH, Ho LC. Transvaginal sonography in the detection of retained products of conception after first-trimester spontaneous abortion. J Clin Ultrasound 2002;30:428.